Xenon Pharmaceuticals (XENE) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Xenon Pharmaceuticals (XENE) over the last 13 years, with Q3 2025 value amounting to -$9.5 million.
- Xenon Pharmaceuticals' Other Gross PP&E Adjustments rose 350.23% to -$9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.5 million, marking a year-over-year increase of 350.23%. This contributed to the annual value of $2.9 million for FY2024, which is 17485.95% up from last year.
- As of Q3 2025, Xenon Pharmaceuticals' Other Gross PP&E Adjustments stood at -$9.5 million, which was up 350.23% from -$8.0 million recorded in Q2 2025.
- Over the past 5 years, Xenon Pharmaceuticals' Other Gross PP&E Adjustments peaked at $2.9 million during Q4 2024, and registered a low of -$10.9 million during Q1 2023.
- In the last 5 years, Xenon Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$8.5 million in 2022 and averaged -$6.8 million.
- As far as peak fluctuations go, Xenon Pharmaceuticals' Other Gross PP&E Adjustments crashed by 127188.94% in 2022, and later surged by 17485.95% in 2024.
- Over the past 5 years, Xenon Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$217000.0 in 2021, then crashed by 1271.89% to -$3.0 million in 2022, then tumbled by 31.47% to -$3.9 million in 2023, then soared by 174.86% to $2.9 million in 2024, then tumbled by 423.48% to -$9.5 million in 2025.
- Its last three reported values are -$9.5 million in Q3 2025, -$8.0 million for Q2 2025, and -$9.2 million during Q1 2025.